Today: October 18, 2017, 9:44 am
  
Health

Novotech signs Central Lab Services Agreement with Sonic Clinical Trials

Novotech signs Central Lab Services Agreement with Sonic Clinical Trials
PR-Inside.com: 2017-06-27 12:51:56
SYDNEY, AUS, June 23, 2017 - (ACN Newswire) - Asia Pacific specialist CRO Novotech announced today it has expanded its business offering to include central lab services through a preferred partnership agreement with Sonic Clinical Trials, an affiliate of international healthcare company, Sonic Healthcare.

Through this unique partnership, Novotech clients will be able to select from a wide menu of assays or biomarkers, access a trial-specific kit assembly service and use a single clinical trial-dedicated laboratory with a global reach, for priority processing of clinical trial samples.


Announcing the new partnership, Novotech CEO Dr. John Moller said, "Novotech has always focused on offering flexible and cost effective clinical trial solutions. Through our partnership with Sonic Clinical Trials, our clients will experience a seamless integration of laboratory services and clinical trial data management by Novotech. From the start to finish, our clients are supported by a team of dedicated project managers.

"Another key benefit to our clients is the fact that Sonic Clinical Trials is pre-audited and an approved Novotech vendor. This removes our clients' need to undertake their own central lab vendor assurance - providing a further savings in cost and clinical trial time."

Sonic Clinical Trials is a registered Research Service Provider (RSP) with AusIndustry, a division of the Australian Government's Department of Industry, Innovation and Science.

"Sonic Clinical Trials' RSP status assists our eligible international clients when accessing the Australian R&D Tax Incentive Scheme. Research from a recent Frost and Sullivan white paper revealed that eligible companies can conduct early stage clinical trials 60% more cheaply in Australia than the USA," explained Dr. Moller.

"Novotech's size and Asia Pacific focus allows our clients to enjoy a direct, hands-on approach to accessing some of the largest patient pools in the world, but we balance this with providing global gold-standard central laboratory services and data management platforms."

About Australian R&D Tax Incentive Scheme

Through the Australian R&D Tax Incentive Scheme, eligible companies may claim a 43.5% R&D tax refund on eligible R&D expenditure. For more information about this scheme, see the joint Novotech / Frost & Sullivan white paper, "Australia: The preferred destination for early phase clinical trials", Mar. 31, 2017. novotech-cro.com/news-events.

About Sonic Clinical Trials

Sonic Clinical Trials is a wholly owned subsidiary of Australian-owned Sonic Healthcare, one of the world's largest specialist medical diagnostics companies, employing more than 33,000 people in Australia, New Zealand, the United Kingdom, Germany, Switzerland, Belgium, Ireland and the USA. Sonic Clinical Trials is a registered Research Service Provider (RSP) with AusIndustry which allows it to assist international clients to register for the Australian R&D Tax Incentive Scheme. To learn more, please visit www.sonicclinicaltrials.com.au.

About Novotech

Headquartered in Sydney, Novotech is internationally recognised as the leading regional full-service contract research organisation (CRO). With a focus on clinical monitoring, Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials in the Asia Pacific region, while it has worldwide reach through its network of strategic partners.

Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management. For more information, please visit www.novotech-cro.com.

Media:

Digital Mantra Group

Susan Fitzpatrick-Napier

AU: +61 2 8218 2144 / USA: +1 650 798 5238

Email: susan@dmgpr.com

Corporate:

Novotech

Justine Lamond

Marketing & Communications Manager

AU: +61 2 8569 1458

Email: communications@novotech-cro.com

Topic: Clinical Trial Results

Sectors: HealthCare

www.acnnewswire.com

From the Asia Corporate News Network

Copyright © 2017 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

Press Information


Published by
ACN Newswire
+65 6304 8926
e-mail
www.acnnewswire.com



# 610 Words
Related Articles
More From The Author
Joint-Stock Bank Almazergienbank launches JCB Card in [..]
Yakutsk/the Sakha Republic (Yakutia) and Tokyo/Japan, June 27, 2017 - (ACN Newswire) - Joint-Stock Bank Almazergienbank, one [..]
JCB International partners with e-commerce PSP, MoneyNetINT
London/Copenhagen, June 27, 2017 - (ACN Newswire) - JCB International Co., Ltd., the international operations subsidiary of [..]
New Eximbank - JCB Platinum Credit Card [..]
Ho Chi Minh City and Tokyo, June 27, 2017 - (ACN Newswire) - Vietnam Export Import Commercial Joint Stock Bank [..]
Suprema to Showcase World's Slimmest FAP20 Fingerprint [..]
SEOUL, KOREA, June 27, 2017 - (ACN Newswire) - Suprema, Inc., a leading global provider of biometrics and ID solutions, [..]
Trillium Inc named to Gartner's Cool Vendors [..]
TOKYO, June 24, 2017 - (JCN Newswire) - Trillium Inc, a leading provider of IoT automotive cyber security solutions, today [..]
 
More From Health
“Reverse Abscopal Effect” in Rheumatoid Arthritis Using [..]
Biotech Holdings Announces Effective Induction of “Reverse Abscopal Effect” in Rheumatoid Arthritis Using Procell Activated Stem [..]
Air Optix Aqua Contacts from Alcon Keeps [..]
Alcon Laboratories’ Air Optix Aqua 6 pack contact lenses bring together two advanced technologies designed to provide long-lasting [..]
Daily Disposable Wear from Sauflon Clariti Keeps [..]
Sauflon Clariti is designed to give customers daily disposable lenses with the benefits of silicone hydrogel material and AquaGen [..]
Understanding Prescription Opioid Addiction, Riverside Clinic [..]
A recent report on ABC News says over the past decade the use of opioid-based prescription painkillers has quadrupled. Over [..]
FSIVF Announces Free Consultation for the Patients [..]
FSIVF has announced the facility of free consultation for the first time for the patients up to 31st October in [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.